Real-world Evidence of the Use of Carfilzomib Among Multiple Myeloma Patients in Europe Who Have Received at Least One Prior Therapy (Use of Carfilzomib In Multiple Myeloma Patients)

05/08/2019
14/03/2024
EU PAS number:
EUPAS30534
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

20150262_01.02.06 Public Redacted Protocol Ver 1.0 English

English (1.9 MB - PDF) View document
Study results
Study results

Abstract of 20150262 Carfilzomib Observational Research Study Report Published Report

English (177.26 KB - PDF) View document
Study report
Other information